J. Ouallet

发表

Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis

H. Amièva, C. Fabrigoule, C. Pachai, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

MS Lesions Are Better Detected with 3D T1 Gradient-Echo Than with 2D T1 Spin-Echo Gadolinium-Enhanced Imaging at 3T

V. Dousset, B. Brochet, M. Saranathan, 2015, American Journal of Neuroradiology.

Microstructural analyses of the posterior cerebellar lobules in relapsing-onset multiple sclerosis and their implication in cognitive impairment

P. Coupé, V. Dousset, M. Deloire, 2017, PloS one.

Expression of TNFα in central neurons of Lewis rat spinal cord after EAE induction

N. Baumann, H. Villarroya, J. Ouallet, 1997 .

Recommendations for a definition of multiple sclerosis in support of early treatment.

F. Blanc, D. Brassat, D. Laplaud, 2012, Revue neurologique.

Multiple sclerosis and pregnancy.

D. Brassat, D. Laplaud, J. de Seze, 2014, Revue neurologique.

First clinical inflammatory demyelinating events of the central nervous system in a population aged over 70 years: A multicentre study.

B. Brochet, G. Edan, D. Brassat, 2019, Multiple sclerosis and related disorders.

Acute Demyelinating Emergencies

J. Ouallet, 2019, Emergencies in Neurology.

Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study

B. Brochet, P. Cabre, D. Brassat, 2015, Journal of Neurology.

CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments

R. D. Du Pasquier, R. Bernard-Valnet, G. Martin-Blondel, 2021, Neurology: Neuroimmunology & Neuroinflammation.

Fas system up-regulation in experimental autoimmune encephalomyelitis

N. Baumann, H. Villarroya, J. Ouallet, 1999, Journal of the Neurological Sciences.

CCR5 Blockade in In ﬂ ammatory PML and PML-IRIS Associated With Chronic In ﬂ ammatory Diseases ’ Treatments

R. D. Pasquier, R. Bernard-Valnet, G. Martin-Blondel, 2022 .

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.

P. Vermersch, M. Giroud, M. Clanet, 2015, Brain : a journal of neurology.

Prion protein accumulation involving the peripheral nervous system in a sporadic case of Creutzfeldt–Jakob disease

K. Petry, B. Brochet, A. Vital, 2003, Neuropathology and applied neurobiology.

A prospective observational post‐marketing study of natalizumab‐treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort

P. Vermersch, M. Clanet, B. Brochet, 2014, European journal of neurology.

Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France

B. Brochet, F. Bonneville, N. Menjot de Champfleur, 2017, Journal of Neurology.

Efficacy of rituximab in refractory neuromyelitis optica

S. Vukusic, B. Brochet, D. Brassat, 2016, Multiple sclerosis.

Expression of TNF alpha in central neurons of Lewis rat spinal cord after EAE induction.

N. Baumann, H. Villarroya, J. Ouallet, 1997, Journal of neuroscience research.

Immune Responses Against the Myelin/Oligodendrocyte Glycoprotein in Experimental Autoimmune Demyelination

P. Villoslada, S. Hauser, J. Ouallet, 2001, Journal of Clinical Immunology.

Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosis.

F. Blanc, D. Brassat, D. Laplaud, 2012, Revue neurologique.

Double‐blind, randomized controlled trial of therapeutic plasma exchanges vs sham exchanges in moderate‐to‐severe relapses of multiple sclerosis

P. Vermersch, M. Deloire, B. Brochet, 2020, Journal of clinical apheresis.

Evaluation of emotional disorders before and during treatment with interferon beta in patients with multiple sclerosis

M. Deloire, B. Brochet, P. Lehert, 2020, Journal of the Neurological Sciences.

Increased risk of multiple sclerosis relapse after in vitro fertilisation

M. Clanet, S. Vukusic, B. Brochet, 2012, Journal of Neurology, Neurosurgery & Psychiatry.

Hemophagocytic Lymphohistiocytosis Gene Mutations in Adult Patients Presenting With CLIPPERS-Like Syndrome

K. Hoang-Xuan, C. Picard, E. Thouvenot, 2021, Neurology: Neuroimmunology & Neuroinflammation.

Association between familial Mediterranean fever and multiple sclerosis: A case series from the JIR cohort and systematic literature review.

S. Amselem, A. Aouba, H. Lévesque, 2021, Multiple sclerosis and related disorders.

Meralgia paresthetica after subcutaneous injection of glatiramer acetate

J. Ouallet, A. Lagueny, 2015, Muscle & nerve.

Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirement.

R. Bordet, E. Thouvenot, W. Camu, 2019, Revue neurologique.

Deciphering Depressive Mood in Relapsing-Remitting and Progressive Multiple Sclerosis and Its Consequence on Quality of Life

M. Deloire, B. Brochet, A. Ruet, 2015, PloS one.

Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study

R. Hupperts, J. Ouallet, A. Bayas, 2015, Expert opinion on drug delivery.

Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination

S. Hauser, H. von Büdingen, J. Ouallet, 2004, European journal of immunology.

Is the Choosing Wisely® campaign model applicable to the management of multiple sclerosis in France? A GRESEP pilot study.

D. Laplaud, J. de Seze, H. Zéphir, 2017, Revue neurologique.

Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study

M. Deloire, K. Petry, B. Brochet, 2013, Journal of Neurology.

Quantitative cerebral perfusion using the PRESTO acquisition scheme

Leif Østergaard, Vincent Dousset, Chrit Moonen, 2004, Journal of magnetic resonance imaging : JMRI.

Posterior lobules of the cerebellum and information processing speed at various stages of multiple sclerosis

P. Coupé, C. Guttmann, N. Moscufo, 2016, Journal of Neurology, Neurosurgery & Psychiatry.

Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome

M. Deloire, B. Brochet, A. Ruet, 2011, Multiple sclerosis.

Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability

D. Brassat, R. Bernard-Valnet, P. Clavelou, 2015, Journal of Neurology.

Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? Comment.

J. Ouallet, 2020, Revue neurologique.

Recommendations for the management of multiple sclerosis relapses.

F. Blanc, D. Brassat, D. Laplaud, 2012, Revue neurologique.

CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy

P. Vermersch, S. Vukusic, B. Brochet, 2016, Neurology.

SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis

B. Brochet, G. Edan, D. Laplaud, 2020, Journal of Neurology.

Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study

V. Dousset, M. Deloire, K. Petry, 2008, Multiple sclerosis.

Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis

P. Vermersch, M. Deloire, B. Brochet, 2017, PloS one.

Pain and Quality of Life in the Early Stages After Multiple Sclerosis Diagnosis: A 2-year Longitudinal Study

M. Deloire, K. Petry, B. Brochet, 2009, The Clinical journal of pain.

Does cerebrospinal fluid analysis add predictive value to magnetic resonance imaging for long term irreversible disability in patients with early multiple sclerosis?

M. Deloire, B. Brochet, A. Ruet, 2015, Journal of the Neurological Sciences.

[Immunomodulatory treatments for multiple sclerosis: lessons from direct comparative studies].

J. Ouallet, 2010, Revue neurologique.

Targeted clinical audits immediately following the establishment of clinical practice guidelines for multiple sclerosis in 17 neurology departments: A pragmatic and collaborative study.

D. Laplaud, J. de Seze, H. Zéphir, 2015, Revue neurologique.

Recommendations for useful serum testing with suspected multiple sclerosis.

F. Blanc, D. Brassat, D. Laplaud, 2013, Revue neurologique.

Preliminary evidence of the cerebellar role on cognitive performances in clinically isolated syndrome

V. Dousset, M. Deloire, B. Brochet, 2018, Journal of the Neurological Sciences.

Papillary adenoma of endolymphatic sac origin: a temporal bone tumor in von Hippel-Lindau disease. Case report.

J. Tubiana, R. van Effenterre, J. Ouallet, 1997, Journal of neurosurgery.

Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society.

C. Louapre, S. Vukusic, C. Mékiès, 2019, Revue neurologique.